Newsroom | 5647 results

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Tempus Founder and CEO Eric Lefkofsky will participate in a fireside chat at 2:00 p.m. ET on Monday, June 8. A live webcast of the conversation will be available here. About Tempus Tempus is a technology company advancing precision medicine through the practi...

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. today announced the submission of a variation application to the European Medicines Agency (EMA) to expand the approved Marketing Authorization Application (MAA) for AQNEURSA® (levacetylleucine) to include the treatment of Ataxia-Telangiectasia (A-T). This submission represents the first regulatory application submitted to the EMA seeking approval of a therapy for the treatment of A-T, a rare, progressive, inherited neurodegenerative disorder. The v...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of...

HOUSTON--(BUSINESS WIRE)--Goldenrod Therapeutics, innovator in brain inflammation treatments for neurological conditions, completed initial close on $6.5 million Series Seed....

YOKOHAMA, Japon--(BUSINESS WIRE)--Yokohama a remporté l'appel d'offres pour la tenue de l'édition 2028 de la réunion annuelle de l'Organization for Human Brain Mapping (OHBM 2028), l'un des plus grands congrès internationaux dans le domaine des sciences du cerveau, confirmant ainsi le statut de la ville en tant que pôle mondial pour les congrès internationaux et les échanges universitaires. La réunion se tiendra au PACIFICO Yokohama du 18 au 22 juin et marquera la deuxième fois seulement que ce...

NORTH BETHESDA, Md.--(BUSINESS WIRE)--The Foundation for the National Institutes of Health announces the winners of the 2026 Charles A. Sanders, MD, Partnership Award....

YOKOHAMA, Giappone--(BUSINESS WIRE)--Yokohama ospiterà la Conferenza annuale 2028 organizzata dalla Organization for Human Brain Mapping (OHBM 2028), tra i principali eventi internazionali dedicati alle neuroscienze, e la città si conferma ancora una volta come polo globale delle convention e degli scambi accademici a livello mondiale. La conferenza, che si svolge solamente per la seconda volta in Giappone, si svolgerà presso il centro PACIFICO Yokohama dal 18 al 22 giugno. OHBM è un'importante...

YOKOHAMA, Japón--(BUSINESS WIRE)--Yokohama ha sido seleccionada como sede del encuentro anual de 2028 de la Organization for Human Brain Mapping (OHBM), uno de los principales congresos internacionales del mundo en el área de las neurociencias. Esta designación consolida el posicionamiento de la ciudad como centro internacional para la celebración de convenciones internacionales y el intercambio académico. El evento, que se celebrará en Japón por segunda vez, tendrá lugar en PACIFICO Yokohama d...

YOKOHAMA, Japan--(BUSINESS WIRE)--Yokohama heeft de organisatie van de jaarlijkse bijeenkomst van de Organization for Human Brain Mapping (OHBM 2028) in de wacht gesleept. Het gaat hier om een van de meest toonaangevende internationale conferenties op het gebied van hersenwetenschap wereldwijd. De bijeenkomst benadrukt de positie van de stad als mondiaal knooppunt voor internationale congressen en academische uitwisseling. De bijeenkomst vindt plaats in PACIFICO Yokohama van 18 tot en met 22 ju...

BOSTON--(BUSINESS WIRE)--Rapid diagnostic clarity enables targeted treatment while avoiding neurosurgery benefiting patients....